Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

336
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
336
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

3.6K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.6K
Drug Biotransformation: Overview01:28

Drug Biotransformation: Overview

2.4K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
2.4K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Favorable response to surufatinib in a patient with necrolytic migratory erythema: A case report.

Open life sciences·2023
Same author

Angioplasty Guidewire-Assisted vs. Conventional Transseptal Puncture for Left Atrial Appendage Occlusion: a multicentre randomized controlled trial.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2023
Same author

Central vertical regulation and urban environment-biased technological progress: evidence from China.

Environmental science and pollution research international·2023
Same author

Smart Dual-Exsolved Self-Assembled Anode Enables Efficient and Robust Methane-Fueled Solid Oxide Fuel Cells.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2023
Same author

Ambient γ-Rays-Mediated Noble-Metal Deposition on Defect-Rich Manganese Oxide for Glycerol-Assisted H<sub>2</sub> Evolution at Industrial-Level Current Density.

Angewandte Chemie (International ed. in English)·2023
Same author

The allometric relationship between carbon emission and economic development in Yangtze River Delta: fusion of multi-source remote sensing nighttime light data.

Environmental science and pollution research international·2023
Same journal

Role of Artificial Intelligence in bioinformatics: Revolutionizing molecular docking and DNA tokenization.

Computational biology and chemistry·2026
Same journal

An interpretable framework for cancer drug response prediction using integrated drug and multi-omics data with a hybrid Bi-LSTM-GRU network.

Computational biology and chemistry·2026
Same journal

SegMWB: A lightweight deep learning framework for microscopic image classification.

Computational biology and chemistry·2026
Same journal

Protein dynamic simulations: From early inception to clinical translation over half a century.

Computational biology and chemistry·2026
Same journal

Integrated omics and virtual screening predict Tabularin as a dual inhibitor of the prognostic microRNAs mir-19a and mir-32 in colorectal cancer.

Computational biology and chemistry·2026
Same journal

In silico characterization of acetyl-CoA carboxylase from Staphylococcus aureus and Escherichia coli: A comparative analysis.

Computational biology and chemistry·2026
関連記事をすべて見る

関連する実験動画

Updated: Jan 13, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K

Transformerとハイパーグラフ畳み込みに基づく薬物間相互作用予測のためのマルチレイヤーハイパーグラフフレームワーク

Lu Shen1, Feng Hu1, Libing Bai1

  • 1Computer College of Qinghai Normal University, Xining, Qinghai 810008, China; The State Key Laboratory of Tibetan Intelligence, Xining, Qinghai 810008, China.

Computational biology and chemistry
|January 11, 2026
PubMed
まとめ
この要約は機械生成です。

薬物間相互作用(DDI)の予測は、安全な投薬にとって不可欠です。Transformerとハイパーグラフ畳み込みを使用した新しいマルチレイヤーハイパーグラフフレームワーク(MLHTHC)は、複雑な関係を捉えることによりDDI予測精度を向上させます。

キーワード:
薬物間相互作用ハイパーグラフ畳み込みマルチレイヤーハイパーグラフトランスフォーマー

さらに関連する動画

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K

関連する実験動画

Last Updated: Jan 13, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K

科学分野:

  • 薬理学と化学情報学。
  • 創薬における人工知能。

背景:

  • 薬物間相互作用(DDI)は、創薬および臨床実践において大きな課題をもたらします。
  • 既存のネットワークモデルは、複雑な多要素の相乗的な薬物間相互作用を捉えるのに苦労しています。
  • 正確なDDI予測は、治療の安全性を高め、投薬レジメンを最適化するために不可欠です。

研究 の 目的:

  • 従来のモデルの限界を克服する薬物間相互作用(DDI)を予測するための高度なフレームワークを開発すること。
  • 複雑な多要素の相乗的な薬物間相互作用を効果的に表現および分析すること。
  • DDI予測の精度と信頼性を向上させること。

主な方法:

  • Transformerとハイパーグラフ畳み込み(MLHTHC)を使用した薬物相互作用予測のためのマルチレイヤーハイパーグラフフレームワークを提案しました。
  • 化学構造、ATCコード、薬物カテゴリ、および標的情報を使用してマルチレイヤー薬物類似性ハイパーグラフを構築しました。
  • 層の重み決定にスペクトルハミング類似性、ノード埋め込みにハイパーグラフ畳み込みネットワーク、特徴融合にTransformer、DDI予測にMLPを採用しました。

主要な成果:

  • MLHTHCモデルは、DPSPやDANNなどの既存の方法と比較して優れたパフォーマンスを示しました。
  • Transformerとハイパーグラフ畳み込みの統合は、薬物間相互作用の予測精度を大幅に向上させました。
  • このフレームワークは、複雑な多要素の相乗的な薬物関係を効果的に捉えます。

結論:

  • 提案されたMLHTHCフレームワークは、薬物間相互作用を予測するための強力で効果的なツールを提供します。
  • このアプローチは、DDI予測能力を向上させることにより、計算薬理学の分野を進歩させます。
  • MLHTHCを使用した正確なDDI予測は、より安全で効果的な薬物療法につながる可能性があります。